If you look at the last patent filed by Dr McFarland and realize all the compounds that are covered - which according to TLT's patent attorney (according to Roger) is standard patent practice.   The compounds range into the 10s if not hundreds of thousands when you realize how many metals were filed and how many compounds are hung off these metal "scaffolds" in various permutations and combinations.  It really is quite staggering and then realize that many of the metals have not been researched in detail before.  

The patent potential of TLT is enormous in a field of research that had become passe to big pharma.     Now we have this new paper that explores Osium for colon cancer - yet another indictation being researched.

Then consider the points made in this latest paper:
1. The compounds are modular nature
2. Lending to "large libraries of multi-generation structures"  (these metal scaffolds can be hung and re-hung with a vast array of compounds - some yet to be fully investigated.) 
3. with low dark toxicity (ie they don't fall apart in the dark - only when activated)
4. with a variety of wavelengths for "tuned" activation that can be tailored to the patient's needs with various cancers at various sizes and depths. 
5. and they proved something completely counter to the past orthodoxy, what were once thought to be toxic metals are now viable for this compound scaffolding.

Then consider this against say chemo, radiation or even BCG, they are more primitive scatter shot approaches - like using a shotgun to go after mice.   They almost always get far more than the mouse and often do significant harm in the process.   Tailored solutions with Theranostic properties and potentially - naturally aquired immunity.   Thousands of potential compound - and they are just scratching the surface!!!

TLT truly sits on the threshold of a revolution in oncology care - perhaps more significant than anything before it with research proceeding on many indications - some unannounced as of yet.   But you can bet these indication will be announced as the papers are released...

Patents filed with potentially thousands of compounds, research papers being published, options in place to reward the team, and ongoing research on NMIBC (with MIBC to follow), GBM, prostate, colon, lung, skin and breast(?) and ???  

And beyond that - there are the rhodium compounds that may very well be some of the best bacteria killers known.